Mark Sorin
@sorin_mark
Followers
625
Following
2K
Media
7
Statuses
301
@McGill_MDPhD | Vanier Scholar @CIHR_IRSC | Passionate about research in lung cancer & immunotherapy
Joined April 2019
Our paper is out in @Nature today! We resolved over 1.6 million cells from 416 lung cancer patients by imaging mass cytometry 😮! Buckle up….
14
22
150
RT @josemorgado: EPIC AND HISTORIC!. Carlos Alcaraz comes back from two sets down for the 1st time, in a Slam final and against his biggest….
0
2K
0
RT @DoctorJSpicer: Check out this awesome new study by the spatial biologists @McGillGCI led by @LysDesharnais @sorin_mark and PI @loganawa….
0
19
0
RT @DoctorJSpicer: Come join @loganawalsh and @IsaOpitz imagine the future of what precision surgery can offer patients when AI supports bi….
0
3
0
Incredibly grateful to have received the CMHF Award! I am thankful for the unwavering support of my mentors, friends and family members who have made this possible. Excited for what is next!.
2024 #CMHFAward recipient @sorin_mark from @McGillMed! He has made important contributions to the field of lung cancer. Inspired by Dr. Phil Gold for his transformative discovery for cancer care and his abundant generosity in mentoring students.
3
0
33
Our work was highlighted in a recent documentary!.
GCI trainee @sorin_mark was featured in the documentary 'La Vie Continue', explaining his contributions to fundamental lung cancer research conducted at the @loganawalsh lab. Watch here: @Mcgillmed.
0
2
19
RT @JAMAOnc: Neoadjuvant chemo-immunotherapy is superior to neoadjuvant chemotherapy across surgical, pathological and efficacy outcomes fo….
0
31
0
RT @maraantonoff: These findings highlight the rationale for recent changes in our practices of neoadjuvant therapy for NSCLC. Disseminatin….
0
4
0
RT @DoctorJSpicer: So very proud of @sorin_mark who I have the pleasure of co-supervising with @loganawalsh @McGillGCI! He came to me with….
0
4
0
RT @BrendonStilesMD: Beautiful study! Congratulations @sorin_mark @DoctorJSpicer and all of the other authors. Incredibly comprehensive co….
0
8
0
RT @ChristianRolfo: 🚨📣Today our editorial with @Al3ssandroRusso in @JAMAOnc The Chemoimmunotherapy Revolution in Resectable NSCLC—The Time….
0
15
0
and Trafford Crump, @loganawalsh, @pierrefiset, @BorisSepesi, @FordePatrick, Tina Cascone, @MARIANOPROVENCI and @DoctorJSpicer for all their mentorship and support! @McGillGCI @mcgillu.
0
2
6
Many thanks to all authors (C. Prosty, L. Ghaleb, K. Nie, K. Katergi, @MHShahzad5, @laurierosedube, @AlineAtallah_, @anikkaswaby, @MDankner).
1
1
5
The current data does not show an OS benefit for patients with baseline tumor PD-L1 levels less than 1% but this could change as the data matures! We also analyze reasons precluding surgery for neoadjuvant chemo-immunotherapy.
1
1
9
We find a significant benefit in overall survival for patients treated with neoadjuvant chemo-immunotherapy vs chemotherapy. We also find a significant benefit in event-free survival for patients with stage II disease and patients with baseline tumor PD-L1 levels less than 1%.
1
2
10
Our paper is out today @JAMAOnc! We report a systematic review and meta-analysis of 43 studies related to neoadjuvant chemo-immunotherapy and chemotherapy involving 5431 patients with resectable NSCLC! .
1
33
98
RT @FRQS1: Bravo au lauréat de janvier du prix Relève étoile Jacques-Genest du @FRQS1, @sorin_mark @mcgillu @McGill_MDPhD @McGillGCI!.#comm….
0
2
0
RT @mcgillu: #McGill research included in @QuebecScience’s top 10 of the year . Chaque année, nos équipes de recher….
0
4
0
Our @Nature paper (Elham Karimi @mo_rezanejad @DanielaQuail @PJoubertPatho @loganawalsh and many others) was selected as a top 10 science discovery in Quebec! The top discovery is determined based on a vote. Vote for lung cancer and AI!
2
5
42
RT @DavidSteensma: Did you ever wonder why our marrow is located inside of our *bones*, #MedTwitter? There’s no a priori anatomical reason….
0
950
0
RT @SonenbergLab: The Pelletier family requests donations to the Memory Fund for Jerry Pelletier supporting cancer research at https://t.co….
0
13
0